Who Owns Lifecore Biomedical Stock?
NASDAQ: LFCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 71.80%
- Held by insiders
- 3.19%
- Institutional holders
- 144
- Institutions 71.8%
- Insiders 3.2%
- Public and other 25.0%
Who owns Lifecore Biomedical stock?
Institutional investors own about 71.8% of Lifecore Biomedical's shares, spread across 144 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.19% of LFCR.
The largest institutional holders are WYNNEFIELD CAPITAL INC (12.41%), Legion Partners Asset Management, LLC (11.77%) and 325 Capital Llc (7.64%). Together, the top 10 institutions control 55.4% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their LFCR positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LFCR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| WYNNEFIELD CAPITAL INC | 4.70M | 12.41% | 0.0% |
| Legion Partners Asset Management, LLC | 4.46M | 11.77% | 0.0% |
| 325 Capital Llc | 2.90M | 7.64% | +33.9% |
| Greenhaven Road Investment Management, L.p. | 2.87M | 7.57% | -10.1% |
| Blackrock Inc. | 2.02M | 5.32% | +0.3% |
| Vanguard Capital Management LLC | 1.29M | 3.40% | 0.0% |
| Geode Capital Management, LLC | 848.62K | 2.24% | -0.8% |
| Morgan Stanley | 737.54K | 1.95% | -4.1% |
| State Street Corporation | 638.08K | 1.68% | -4.5% |
| Quinn Opportunity Partners, LLC | 539.45K | 1.42% | +18.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LFCR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 822.11K | 2.17% |
| iShares Trust-iShares Russell 2000 ETF | 733.18K | 1.93% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 435.40K | 1.15% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 305.21K | 0.81% |
| iShares Trust-iShares Russell 2000 Value ETF | 275.62K | 0.73% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 178.72K | 0.47% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 163.14K | 0.43% |
| iShares Trust-iShares Micro-Cap ETF | 90.53K | 0.24% |
| EQ Advisors Trust-1290 VT GAMCO Small Company Value Portfolio | 78.00K | 0.21% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 69.84K | 0.18% |
Frequently asked questions
Who is the largest shareholder of Lifecore Biomedical?
WYNNEFIELD CAPITAL INC is the largest institutional shareholder of LFCR, owning 12.41% of shares outstanding (4.70M shares) as of its latest 13F filing.
What percentage of Lifecore Biomedical is owned by institutions?
Institutions own about 71.8% of LFCR shares and 74.2% of the public float.
How much of Lifecore Biomedical do insiders own?
Insiders, such as officers and directors, own about 3.19% of LFCR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.